RI
TARS icon

RTW Investments’s Tarsus Pharmaceuticals TARS Stock Holding History

RTW Investments’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211M Buy
3,357,059
+11,034
+0.3% +$705K 1.8% 21
2026
Q1 		$235M Buy
3,346,025
+10,705
+0.3% +$748K 2.34% 12
2025
Q4 		$273M Buy
3,335,320
+157,884
+5% +$11.8M 2.74% 8
2025
Q3 		$189M Buy
3,177,436
+65,756
+2% +$3.24M 2.33% 13
2025
Q2 		$126M Sell
3,111,680
-204,352
-6% -$9.2M 1.8% 20
2025
Q1 		$170M Buy
3,316,032
+79,483
+2% +$3.93M 2.61% 15
2024
Q4 		$179M Sell
3,236,549
-175,937
-5% -$7.99M 2.71% 14
2024
Q3 		$112M Hold
3,412,486
– – 1.62% 26
2024
Q2 		$92.8M Buy
3,412,486
+140,145
+4% +$4.71M 1.44% 25
2024
Q1 		$119M Buy
3,272,341
+120,000
+4% +$3.53M 1.76% 22
2023
Q4 		$63.8M Buy
3,152,341
+271,640
+9% +$4.54M 1% 28
2023
Q3 		$51.2M Buy
2,880,701
+332,576
+13% +$5.89M 1.08% 24
2023
Q2 		$46M Hold
2,548,125
– – 0.88% 28
2023
Q1 		$32M Hold
2,548,125
– – 0.67% 30
2022
Q4 		$37.4M Buy
2,548,125
+524,946
+26% +$8.69M 0.76% 30
2022
Q3 		$34.6M Buy
2,023,179
+9,578
+0.5% +$152K 0.8% 35
2022
Q2 		$29.4M Hold
2,013,601
– – 0.76% 34
2022
Q1 		$33.9M Hold
2,013,601
– – 0.7% 41
2021
Q4 		$45.3M Hold
2,013,601
– – 0.66% 48
2021
Q3 		$43.4M Hold
2,013,601
– – 0.65% 43
2021
Q2 		$58.4M Sell
2,013,601
-450,000
-18% -$14.1M 0.88% 32
2021
Q1 		$79.1M Hold
2,463,601
– – 1.23% 29
2020
Q4 		$99M Buy
+2,463,601
New +$70.2M 1.66% 17

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RTW Investments's TARS Position: Q2 2026 in Review

RTW Investments increased its Tarsus Pharmaceuticals (TARS) stake by 0.33% in Q2 2026, buying an estimated $705K and bringing the position to 3,357,059 shares worth $211M. The position accounts for 1.8% of the portfolio, ranked #21.

RTW Investments first reported a position in TARS in Q4 2020 and has held it in 23 quarters since. The position peaked at $273M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • RTW Investments held 3,357,059 shares of Tarsus Pharmaceuticals worth $211M as of Q2 2026.
  • RTW Investments bought 11,034 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $705K.
  • Tarsus Pharmaceuticals made up 1.8% of RTW Investments's portfolio in Q2 2026, its #21 holding.
  • RTW Investments first reported a position in Tarsus Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • RTW Investments's Tarsus Pharmaceuticals position peaked at $273M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.